Alert: the m&a class action firm announces the investigation of albireo pharma, inc. - albo

New york , jan. 9, 2023 /prnewswire/ -- juan monteverde , founder and managing partner of the class action firm monteverde & associates pc (the "m&a class action firm"), a national securities firm rated top 50 in the 2018-2021 iss securities class action services report and headquartered at the empire state building in new york city, is investigating albireo pharma, inc. (nasdaq: albo), relating to its proposed sale to ipsen. under the terms of the agreement, albo shareholders are expected to receive $42.00 in cash per share they own, plus one contingent value right worth a deferred $10.00 per share.
ALBO Ratings Summary
ALBO Quant Ranking